Arch Oncology competitorsClear all

Priothera's top competitors include Tollys and Apexigen.

	Priothera Priothera is a company that develops receptor modulators intended to improve the lives of patients suffering from hematological malignancies.	Tollys Tollys is a biopharmaceutical company focused on innate immunity, particularly on the biology and modulation of the TLR3 receptor.	Apexigen Apexigen is a company that develops antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology.
Founding Date	Founding Date 2020	Founding Date 2015	Founding Date 2010
Type	Type Private	Type Private	Type Private
Tags	Tags Healthcare biotech drug development healthtech oncology pharma	Tags Healthcare biotech drug development healthtech oncology pharma	Tags Healthcare biotech drug development healthtech oncology pharma
Locations	Locations Dublin, IE HQ	Locations Lyon, FR HQ Lyon, FR	Locations San Carlos, US HQ
Employees	Employees N/A	Employees N/A	Employees 365% decrease
Alexa Website Rank	Alexa Website Rank 183065	Alexa Website Rank N/A	Alexa Website Rank 148563
Employee Rating	Employee Rating N/A	Employee Rating 3.5	Employee Rating 3.8
Funding
Latest funding round	Latest funding round $ 35.5m (over 1 year ago)	Latest funding round $ 2.5m (almost 2 years ago)	Latest funding round $ 65m (about 2 years ago)
Total funding raised	Total funding raised $ 35.5m	Total funding raised $ 6.8m	Total funding raised $ 158m

For sources of this data, please see the company profile

Lyon, FR

Tollys is a biopharmaceutical company focused on innate immunity, particularly on the biology and modulation of the TLR3 receptor.

San Carlos, US

Employees

36↓ 5% decrease

Apexigen is a company that develops antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology.

Funding